Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by VA Office of Research and Development
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT01590277
First received: April 30, 2012
Last updated: May 20, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)